Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 603

1.

Hybrid of Compressed Sensing and Parallel Imaging Applied to Three-dimensional Isotropic T2-weighted Turbo Spin-echo MR Imaging of the Lumbar Spine.

Morita K, Nakaura T, Maruyama N, Iyama Y, Oda S, Utsunomiya D, Namimoto T, Kitajima M, Yoneyama M, Yamashita Y.

Magn Reson Med Sci. 2019 Mar 15. doi: 10.2463/mrms.mp.2018-0132. [Epub ahead of print]

2.

REMODEL: Rethinking Deep CNN Models to Detect and Count on a NeuroSynaptic System.

Shukla R, Lipasti M, Van Essen B, Moody A, Maruyama N.

Front Neurosci. 2019 Feb 22;13:4. doi: 10.3389/fnins.2019.00004. eCollection 2019.

3.

Development of monoclonal mouse antibodies that specifically recognize pancreatic polypeptide.

Hara A, Nakagawa Y, Nakao K, Tamaki M, Ikemoto T, Shimada M, Matsuhisa M, Mizukami H, Maruyama N, Watada H, Fujitani Y.

Endocr J. 2019 Mar 6. doi: 10.1507/endocrj.EJ18-0441. [Epub ahead of print]

4.

Ses i 1-specific immunoglobulin E and sesame oral food challenge results.

Yanagida N, Ejiri Y, Takeishi D, Sato S, Maruyama N, Takahashi K, Nagakura KI, Ogura K, Asaumi T, Ebisawa M.

J Allergy Clin Immunol Pract. 2019 Mar 2. pii: S2213-2198(19)30198-9. doi: 10.1016/j.jaip.2019.02.022. [Epub ahead of print] No abstract available.

PMID:
30836231
5.

Activation of the hypothalamic paraventricular nucleus by acute intermittent hypoxia: Implications for sympathetic long-term facilitation neuroplasticity.

Maruyama NO, Mitchell NC, Truong TT, Toney GM.

Exp Neurol. 2019 Apr;314:1-8. doi: 10.1016/j.expneurol.2018.12.011. Epub 2018 Dec 31.

PMID:
30605624
6.

Efficacy of L-carnitine supplementation for improving lean body mass and physical function in patients on hemodialysis: a randomized controlled trial.

Maruyama T, Maruyama N, Higuchi T, Nagura C, Takashima H, Kitai M, Utsunomiya K, Tei R, Furukawa T, Yamazaki T, Okawa E, Ando H, Kikuchi F, Abe M.

Eur J Clin Nutr. 2019 Feb;73(2):293-301. doi: 10.1038/s41430-018-0348-y. Epub 2018 Oct 23.

PMID:
30353121
7.

Senescence marker protein 30 protects intestinal epithelial cells against inflammation-induced cell death by enhancing Nrf2 activity.

Choo J, Heo G, Kim SJ, Lee Y, Ishigami A, Maruyama N, Chung HY, Im E.

Biochim Biophys Acta Mol Basis Dis. 2018 Dec;1864(12):3668-3678. doi: 10.1016/j.bbadis.2018.09.031. Epub 2018 Sep 26.

PMID:
30266650
8.

Triple primary cancer of the head and neck, skin and prostate: A case report and literature review.

Maruyama N, Nakasone T, Arakaki O, Matsumoto H, Maruyama T, Matayoshi A, Goto T, Saito S, Yoshimi N, Arasaki A, Nishihara K.

Oncol Lett. 2018 Oct;16(4):5249-5256. doi: 10.3892/ol.2018.9294. Epub 2018 Aug 10.

9.

Targets and Therapeutics for Glycemic Control in Diabetes Patients on Hemodialysis.

Maruyama N, Abe M.

Contrib Nephrol. 2018;196:37-43. doi: 10.1159/000485695. Epub 2018 Jul 24.

PMID:
30041202
10.

Continuous hemofiltration model using porcine blood for comparing filter life.

Kurihara Y, Ueki S, Kokubo K, Kobayashi Y, Ebine T, Murakami K, Ushiroda Y, Maruyama N, Tsukao H, Kobayashi K, Kobayashi H.

J Artif Organs. 2018 Sep;21(3):332-339. doi: 10.1007/s10047-018-1060-3. Epub 2018 Jul 24.

PMID:
30039456
11.

Gly m 5/Gly m 8 fusion component as a potential novel candidate molecule for diagnosing soya bean allergy in Japanese children.

Maruyama N, Sato S, Cabanos C, Tanaka A, Ito K, Ebisawa M.

Clin Exp Allergy. 2018 Dec;48(12):1726-1734. doi: 10.1111/cea.13231. Epub 2018 Aug 13.

PMID:
29992645
12.

Effect of Sucroferric Oxyhydroxide on Fibroblast Growth Factor 23 Levels in Hemodialysis Patients.

Otsuki T, Utsunomiya K, Moriuchi M, Horikoshi S, Okamura M, Suzuki H, Okamura M, Maruyama N, Shibahara N, Abe M.

Nephron. 2018;140(3):161-168. doi: 10.1159/000490903. Epub 2018 Jul 10.

PMID:
29991053
13.

Triple primary malignancies of surface osteosarcoma of jaw, myelodysplastic syndrome and colorectal cancer as a second primary cancer detected by PET2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography: A case report.

Maruyama N, Nishihara K, Nakasone T, Saio M, Maruyama T, Tedokon I, Ohira T, Nimura F, Matayoshi A, Karube KN, Yoshimi N, Arasaki A.

Oncol Lett. 2018 Jun;15(6):9901-9907. doi: 10.3892/ol.2018.8594. Epub 2018 Apr 27.

14.

Renoprotective effects of canagliflozin, a sodium glucose cotransporter 2 inhibitor, in type 2 diabetes patients with chronic kidney disease: A randomized open-label prospective trial.

Takashima H, Yoshida Y, Nagura C, Furukawa T, Tei R, Maruyama T, Maruyama N, Abe M.

Diab Vasc Dis Res. 2018 Sep;15(5):469-472. doi: 10.1177/1479164118782872. Epub 2018 Jun 20.

PMID:
29923427
15.

Nuclear Protein in Testis Carcinoma of the Thorax.

Maruyama N, Hikiishi A, Suginaka M, Furukawa K, Ogawa K, Nakamura N, Yoshida Y, Takata M, Nishijima M, Otani K, Kamimori T, Fujiwara H, Yoshimatsu Y, Ueda K.

Intern Med. 2018 Nov 1;57(21):3169-3173. doi: 10.2169/internalmedicine.0434-17. Epub 2018 Jun 6.

16.

Ferric Citrate Decreases Fibroblast Growth Factor 23 and Improves Erythropoietin Responsiveness in Hemodialysis Patients.

Maruyama N, Otsuki T, Yoshida Y, Nagura C, Kitai M, Shibahara N, Tomita H, Maruyama T, Abe M.

Am J Nephrol. 2018;47(6):406-414. doi: 10.1159/000489964. Epub 2018 Jun 6.

PMID:
29874654
17.

Activation of disulfide bond cleavage triggered by hydrophobization and lipophilization of functionalized dihydroasparagusic acid.

Inagaki F, Momose M, Maruyama N, Matsuura K, Matsunaga T, Mukai C.

Org Biomol Chem. 2018 Jun 13;16(23):4320-4324. doi: 10.1039/c8ob01055b.

PMID:
29808899
18.

Dedifferentiated liposarcoma of the oral floor: A case study and literature review of 50 cases of head and neck neoplasm.

Nimura F, Nakasone T, Matsumoto H, Maruyama T, Matayoshi A, Maruyama N, Yoshimi N, Arasaki A, Nishihara K.

Oncol Lett. 2018 May;15(5):7681-7688. doi: 10.3892/ol.2018.8274. Epub 2018 Mar 15.

19.

An inline ion-exchange system in a chemiluminescence-based analyzer for direct analysis of N-nitrosamines in treated wastewater.

Kodamatani H, Roback SL, Plumlee MH, Ishida KP, Masunaga H, Maruyama N, Fujioka T.

J Chromatogr A. 2018 Jun 8;1553:51-56. doi: 10.1016/j.chroma.2018.04.030. Epub 2018 Apr 13.

PMID:
29691056
20.

Specific IgE for Fag e 3 Predicts Oral Buckwheat Food Challenge Test Results and Anaphylaxis: A Pilot Study.

Yanagida N, Sato S, Maruyama N, Takahashi K, Nagakura KI, Ogura K, Asaumi T, Ebisawa M.

Int Arch Allergy Immunol. 2018;176(1):8-14. doi: 10.1159/000487135. Epub 2018 Apr 10.

21.

Evaluation of changes in periodontal bacteria in healthy dogs over 6 months using quantitative real-time PCR.

Maruyama N, Mori A, Shono S, Oda H, Sako T.

Pol J Vet Sci. 2018 Mar;21(1):127-132. doi: 10.24425/119030.

PMID:
29623999
22.

Difficult intubation due to unknown congenital tracheal stenosis in the adult: a case report and literature review.

Yoshimatsu Y, Morita R, Suginaka M, Furukawa K, Nakamura N, Yamairi K, Maruyama N, Kaji M, Kamimori T, Fujiwara H.

J Thorac Dis. 2018 Feb;10(2):E93-E97. doi: 10.21037/jtd.2018.01.36.

23.

Association of circulating ANGPTL 3, 4, and 8 levels with medical status in a population undergoing routine medical checkups: A cross-sectional study.

Morinaga J, Zhao J, Endo M, Kadomatsu T, Miyata K, Sugizaki T, Okadome Y, Tian Z, Horiguchi H, Miyashita K, Maruyama N, Mukoyama M, Oike Y.

PLoS One. 2018 Mar 14;13(3):e0193731. doi: 10.1371/journal.pone.0193731. eCollection 2018.

24.

Efficacy and safety of canagliflozin as add-on therapy to a glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52-week, open-label, phase IV study.

Harashima SI, Inagaki N, Kondo K, Maruyama N, Otsuka M, Kawaguchi Y, Watanabe Y.

Diabetes Obes Metab. 2018 Jul;20(7):1770-1775. doi: 10.1111/dom.13267. Epub 2018 Mar 24.

25.

Improved effect of ultra-pure soft water on skin water content in older adults.

Matsuda K, Makita Y, Nagaoka T, Sasaki Y, Maruyama N, Tanaka A, Matsuda H.

Geriatr Gerontol Int. 2018 Feb;18(2):364-365. doi: 10.1111/ggi.13200. No abstract available.

PMID:
29461013
26.

Airway inflammation after epicutaneous sensitization of mice requires protease activity of low-dose allergen inhalation.

Nishioka I, Takai T, Maruyama N, Kamijo S, Suchiva P, Suzuki M, Kunimine S, Ochi H, Shimura S, Sudo K, Ogawa H, Okumura K, Ikeda S.

J Allergy Clin Immunol. 2018 Jun;141(6):2271-2273.e7. doi: 10.1016/j.jaci.2017.11.035. Epub 2018 Feb 6. No abstract available.

PMID:
29426602
27.

A vacuolar sorting receptor-independent sorting mechanism for storage vacuoles in soybean seeds.

Maruyama N, Matsuoka Y, Yokoyama K, Takagi K, Yamada T, Hasegawa H, Terakawa T, Ishimoto M.

Sci Rep. 2018 Jan 18;8(1):1108. doi: 10.1038/s41598-017-18697-w.

28.

Intra- and inter-subject variability for increases in serum ketone bodies in patients with type 2 diabetes treated with the sodium glucose co-transporter 2 inhibitor canagliflozin.

Polidori D, Iijima H, Goda M, Maruyama N, Inagaki N, Crawford PA.

Diabetes Obes Metab. 2018 May;20(5):1321-1326. doi: 10.1111/dom.13224. Epub 2018 Feb 14.

29.

Diagnostic and clinical significance of the titin fragment in urine of Duchenne muscular dystrophy patients.

Awano H, Matsumoto M, Nagai M, Shirakawa T, Maruyama N, Iijima K, Nabeshima YI, Matsuo M.

Clin Chim Acta. 2018 Jan;476:111-116. doi: 10.1016/j.cca.2017.11.024. Epub 2017 Nov 23.

PMID:
29175173
30.

Long-term efficacy and safety of canagliflozin in combination with insulin in Japanese patients with type 2 diabetes mellitus.

Inagaki N, Harashima SI, Kaku K, Kondo K, Maruyama N, Otsuka M, Kawaguchi Y, Iijima H.

Diabetes Obes Metab. 2018 Apr;20(4):812-820. doi: 10.1111/dom.13152. Epub 2017 Dec 5.

31.

Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, placebo-controlled, parallel-group comparative study.

Kadowaki T, Inagaki N, Kondo K, Nishimura K, Kaneko G, Maruyama N, Nakanishi N, Gouda M, Iijima H, Watanabe Y.

Diabetes Obes Metab. 2018 Feb;20(2):453-457. doi: 10.1111/dom.13079. Epub 2017 Sep 15.

32.

Long-term safety and efficacy of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes.

Kadowaki T, Inagaki N, Kondo K, Nishimura K, Kaneko G, Maruyama N, Nakanishi N, Watanabe Y, Gouda M, Iijima H.

Diabetes Obes Metab. 2018 Jan;20(1):77-84. doi: 10.1111/dom.13038. Epub 2017 Jul 31.

33.

Effect of essential amino acids on enteroids: Methionine deprivation suppresses proliferation and affects differentiation in enteroid stem cells.

Saito Y, Iwatsuki K, Hanyu H, Maruyama N, Aihara E, Tadaishi M, Shimizu M, Kobayashi-Hattori K.

Biochem Biophys Res Commun. 2017 Jun 17;488(1):171-176. doi: 10.1016/j.bbrc.2017.05.029. Epub 2017 May 5.

PMID:
28483523
34.

Loss of MURC/Cavin-4 induces JNK and MMP-9 activity enhancement in vascular smooth muscle cells and exacerbates abdominal aortic aneurysm.

Miyagawa K, Ogata T, Ueyama T, Kasahara T, Nakanishi N, Naito D, Taniguchi T, Hamaoka T, Maruyama N, Nishi M, Kimura T, Yamada H, Aoki H, Matoba S.

Biochem Biophys Res Commun. 2017 Jun 3;487(3):587-593. doi: 10.1016/j.bbrc.2017.04.096. Epub 2017 Apr 19.

PMID:
28433630
35.

Orbicularis oculi muscle tightening for involutional entropion.

Nemoto H, Togo T, Maruyama N, Miyabe K, Nakae S, Sumiya N.

J Plast Reconstr Aesthet Surg. 2017 Jul;70(7):946-951. doi: 10.1016/j.bjps.2017.01.017. Epub 2017 Feb 17.

PMID:
28268157
36.

Skin Treatment with Detergent Promotes Protease Allergen-Dependent Epicutaneous Sensitization in a Manner Different from Tape Stripping in Mice.

Ochi H, Takai T, Shimura S, Maruyama N, Nishioka I, Kamijo S, Iida H, Nakae S, Ogawa H, Okumura K, Ikeda S.

J Invest Dermatol. 2017 Jul;137(7):1578-1582. doi: 10.1016/j.jid.2017.02.970. Epub 2017 Mar 1. No abstract available.

37.

Candida albicans Adheres to Chitin by Recognizing N-acetylglucosamine (GlcNAc).

Ishijima SA, Yamada T, Maruyama N, Abe S.

Med Mycol J. 2017;58(1):E15-E21. doi: 10.3314/mmj.16-00007.

38.

Photocyclization of photoswitches with high enantioselectivity in human serum albumin in an artificial environment.

Kawamura K, Osawa K, Watanobe Y, Saeki Y, Maruyama N, Yokoyama Y.

Chem Commun (Camb). 2017 Mar 14;53(22):3181-3184. doi: 10.1039/c6cc10197f.

PMID:
28195280
39.

Efficacy and safety of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes mellitus: Results of a 24-week, randomized, double-blind, placebo-controlled trial.

Kadowaki T, Inagaki N, Kondo K, Nishimura K, Kaneko G, Maruyama N, Nakanishi N, Iijima H, Watanabe Y, Gouda M.

Diabetes Obes Metab. 2017 Jun;19(6):874-882. doi: 10.1111/dom.12898. Epub 2017 Mar 31.

40.

Inhibition of Neutrophil Adhesion and Antimicrobial Activity by Diluted Hydrosol Prepared from Rosa damascena.

Maruyama N, Tansho-Nagakawa S, Miyazaki C, Shimomura K, Ono Y, Abe S.

Biol Pharm Bull. 2017;40(2):161-168. doi: 10.1248/bpb.b16-00644. Erratum in: Biol Pharm Bull. 2017;40(4):546.

41.

Establishment of a highly sensitive sandwich ELISA for the N-terminal fragment of titin in urine.

Maruyama N, Asai T, Abe C, Inada A, Kawauchi T, Miyashita K, Maeda M, Matsuo M, Nabeshima YI.

Sci Rep. 2016 Dec 19;6:39375. doi: 10.1038/srep39375.

42.

Factors Affecting Canagliflozin-Induced Transient Urine Volume Increase in Patients with Type 2 Diabetes Mellitus.

Tanaka H, Takano K, Iijima H, Kubo H, Maruyama N, Hashimoto T, Arakawa K, Togo M, Inagaki N, Kaku K.

Adv Ther. 2017 Feb;34(2):436-451. doi: 10.1007/s12325-016-0457-8. Epub 2016 Dec 15.

43.

Establishment of mouse Mac-2 binding protein enzyme-linked immunosorbent assay and its application for mouse chronic liver disease models.

Iwata A, Kamada Y, Ebisutani Y, Yamamoto A, Ueda Y, Arai H, Fujii H, Takamatsu S, Maruyama N, Maeda M, Takehara T, Miyoshi E.

Hepatol Res. 2017 Aug;47(9):902-909. doi: 10.1111/hepr.12819. Epub 2016 Oct 13.

PMID:
27615366
44.

PTRF/Cavin-1 Deficiency Causes Cardiac Dysfunction Accompanied by Cardiomyocyte Hypertrophy and Cardiac Fibrosis.

Taniguchi T, Maruyama N, Ogata T, Kasahara T, Nakanishi N, Miyagawa K, Naito D, Hamaoka T, Nishi M, Matoba S, Ueyama T.

PLoS One. 2016 Sep 9;11(9):e0162513. doi: 10.1371/journal.pone.0162513. eCollection 2016.

45.

Deposition mode of transforming growth factor-β expressed in transgenic rice seed.

Takaiwa F, Yang L, Maruyama N, Wakasa Y, Ozawa K.

Plant Cell Rep. 2016 Dec;35(12):2461-2473. Epub 2016 Aug 31.

PMID:
27580728
46.

[Simple Formula to Predict Residual Amount of Continuously Infused Rocuronium in the Body].

Kobayashi S, Ishii N, Maruyama N, Ishiyama Y, Tsuruno K, Morimoto M, Ihara M, Kamiutsuri K, Ido K, Yonemoto N, Nagao N, Adachi M.

Masui. 2016 Sep;65(9):976-981. Japanese.

PMID:
30358330
47.

MURC deficiency in smooth muscle attenuates pulmonary hypertension.

Nakanishi N, Ogata T, Naito D, Miyagawa K, Taniguchi T, Hamaoka T, Maruyama N, Kasahara T, Nishi M, Matoba S, Ueyama T.

Nat Commun. 2016 Aug 22;7:12417. doi: 10.1038/ncomms12417.

48.

Recent advances in component resolved diagnosis in food allergy.

Borres MP, Maruyama N, Sato S, Ebisawa M.

Allergol Int. 2016 Oct;65(4):378-387. doi: 10.1016/j.alit.2016.07.002. Epub 2016 Aug 16. Review.

49.

Usefulness of peripheral arterial signs in the evaluation of aortic regurgitation.

Shiraishi H, Shirayama T, Maruyama N, Kaimoto S, Otakara A, Kurimoto R, Nakanishi N, Nakamura T, Yamano T, Matsumuro A, Doi K, Yaku H, Matoba S.

J Cardiol. 2017 May;69(5):769-773. doi: 10.1016/j.jjcc.2016.07.005. Epub 2016 Aug 5.

50.

Distinct interacting core taxa in co-occurrence networks enable discrimination of polymicrobial oral diseases with similar symptoms.

Shiba T, Watanabe T, Kachi H, Koyanagi T, Maruyama N, Murase K, Takeuchi Y, Maruyama F, Izumi Y, Nakagawa I.

Sci Rep. 2016 Aug 8;6:30997. doi: 10.1038/srep30997.

Supplemental Content

Loading ...
Support Center